File photo of NIAID director Dr. Anthony Fauci.
Sourced from the net by Tracy Cabrera
HAMILTON, MONTANA — Many of those who were afflicted with Covid-19 have remained sick in several instances and this torturous cycle of debilitating brain fog, fatigue, and muscle pain has been referred to by mostly informal names thus far, such as ‘long Covid’.
But during a recent, press conference attended by the National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci, the condition has been finally referred to by an official name: PASC.
“Many of you are now aware of what had long been called ‘long Covid’ but actually, what that really is post-acute sequelae of SARS-CoV-2 infection, which we’re now referring to as PASC,” Fauci disclosed in the conference.
With some studies showing that as many as one-third of patients with Covid-19 may experience lingering symptoms, the National Institutes of Health (NIH) over the weekend that it is launching an analysis to figure out what is causing the constellation of symptoms.
“It’s very difficult to treat something when you don’t know what the target of the treatment is, and that’s the reason why it’s extremely important to take a look at these individuals, not only the scope of this and not only, you know, the depth and breadth of the symptoms, but also to try and have some correlate that actually is the pathophysiological correlate,” Fauci pointed out.
Dr. Bradley Sanville, a pulmonologist at UC Davis who treats PASC patients at the facility’s Post-Covid Clinic, said that Fauci’s announcement is a significant development.
“The name is important. I think the colloquial name of ‘long haulers’ is fine and helps patients identify with others,” Sanville revealed.
“But from a medical standpoint, naming is important because it gives it a little bit of veracity that it otherwise wouldn’t have,” he added.
The well-known pulmonologist noted that the inclusion of ‘sequelae’— which technically refers to as “aftereffect of a disease”—helps capture the large variety of symptoms that long-haulers experience.
“It’s different then using ‘disease’; the disease is something that is much more discreet and we know has particular pathophysiology behind it. Whereas a syndrome, or sequelae, is something that’s associated with—well, in this case, SARS-CoV-2 virus. But we don’t know exactly what’s causing it, and it’s probably a collection of a couple of different things happening,” he further said.
Sanville is hopeful that this name will add to the legitimacy of this condition, which he currently sees at a rate of six new patients a week.
“Giving it a name that physicians and nurses understand helps it kind of give some reality too. I had a patient the other day who complained that the doctor she had seen had just written her off as being neurotic. So—not that I have any magic answers necessarily for all these patients—but it’s so prevalent that it seems unlikely that . . . it’s just in people’s brains,” he stressed.
Equally appreciative of the new name is Dr. Ruwanthi Titano, a cardiology specialist at Mount Sinai has treated more than 260 patients with cardiac symptoms of PASC.
“I think this is an appropriate name—showing that it’s after the acute illness, there are these long-term sequelae that we’re really seeing coming out of the woodwork,” Titano said, citing that she is particularly happy to hear about NIH’s plans to study the condition, for which symptoms range from shortness of breath and heart palpitations to hair loss and numbness. (AI/MTVN)